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NK cells mediate immunity against tumors 
and pathogens by producing effector cytokines, 
such as IFN-, and by secreting lytic granules 
that kill target cells. NK cell activation and 
function are determined by a balance of signals 
transmitted by inhibitory and activating NK cell 
receptors (NKRs) (1). Many of the inhibitory 
NKRs recognize self-ligands such as MHC class 
Ia, which are recognized by inhibitory Ly49 re-
ceptors in mice and inhibitory killer immuno-
globulin-like receptors (KIRs) in humans, and 
MHC class Ib molecules, which are recognized 
by CD94/NKG2A in both species. Activating 
NKRs can recognize host-encoded molecules 
that are induced by transformation or infection 
of the host cells (e.g., NKG2D ligands), and 
some activating NKRs recognize non–self-li-
gands, for example, the mouse CMV (MCMV) 
m157 glycoprotein, which is recognized by 
Ly49H (2–6). Activating NKRs typically have 
short intracellular domains that lack known sig-
naling motifs and instead associate with signal-
ing subunits, including the immunoreceptor 
tyrosine-based activation motif (ITAM)–bearing 
CD3-, FcRI, and DAP12 (also referred to as 
KARAP) proteins and the YINM motif-con-
taining DAP10 adaptor (7, 8). In the absence of 
an appropriate signaling subunit, many of the ac-
tivating NKRs (e.g., NKG2D, CD16, KIR3DS1, 
and the CD94/NKG2C heterodimer) are not 
stably expressed on the cell surface (8–11). In 
humans, some of the activating NKRs, such as 
CD16, can associate interchangeably with both 
the ITAM-bearing FcRI and CD3- subunits 
for stable expression and signaling (12).
DAP12 associates with multiple activat-
ing NKRs, including the human and mouse 
CD94/NKG2C heterodimers, the mouse Ly49H 
and Ly49D receptors, human NKp44, and the 
CORRESPONDENCE  
Lewis L. Lanier: 
Lewis.Lanier@ucsf.edu
Abbreviations used: ITAM, 
immunoreceptor tyrosine-based 
activation motif; KIR, killer 
immunoglobulin-like receptors; 
MCMV, mouse CMV; MFI, 
mean fluorescence intensity; 
NKR, NK cell receptor.
Ly49H signaling through DAP10 is essential 
for optimal natural killer cell responses  
to mouse cytomegalovirus infection
Mark T. Orr,1 Joseph C. Sun,1 David G.T. Hesslein,1 Hisashi Arase,2  
Joseph H. Phillips,3 Toshiyuki Takai,4 and Lewis L. Lanier1
1Department of Microbiology and Immunology and the Cancer Research Institute, University of California, San Francisco,  
San Francisco, CA 94143
2Department of Immunochemistry, World Premier International Immunology Frontier Research Center and Research Institute 
for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan
3Department of Discovery Research, Schering-Plough Biopharma, Palo Alto, CA 94304
4Department of Experimental Immunology, Institute of Development, Aging, and Cancer, Tohoku University, Aoba,  
Sendai 980-8575, Japan
The activating natural killer (NK) cell receptor Ly49H recognizes the mouse cytomegalovi-
rus (MCMV) m157 glycoprotein expressed on the surface of infected cells and is required 
for protection against MCMV. Although Ly49H has previously been shown to signal via 
DAP12, we now show that Ly49H must also associate with and signal via DAP10 for opti-
mal function. In the absence of DAP12, DAP10 enables Ly49H-mediated killing of m157-
bearing target cells, proliferation in response to MCMV infection, and partial protection 
against MCMV. DAP10-deficient Ly49H+ NK cells, expressing only Ly49H–DAP12 receptor 
complexes, are partially impaired in their ability to proliferate during MCMV infection, 
display diminished ERK1/2 activation, produce less IFN- upon Ly49H engagement, and 
demonstrate reduced control of MCMV infection. Deletion of both DAP10 and DAP12 
completely abrogates Ly49H surface expression and control of MCMV infection. Thus, 
optimal NK cell–mediated immunity to MCMV depends on Ly49H signaling through both 
DAP10 and DAP12.
© 2009 Orr et al. This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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active and whether they contribute to host protection in 
vivo. In this paper, we demonstrate that Ly49H associates 
with DAP10 in addition to DAP12 and that Ly49H–DAP10 
complexes are functional and necessary for optimal control of 
MCMV infection. Deletion of either signaling subunit re-
duces surface expression of Ly49H, and loss of both DAP10 
and DAP12 completely ablates Ly49H surface expression. In 
the absence of DAP12, Ly49H can signal via DAP10 to in-
duce NK cell responses that partially control MCMV infec-
tion. In contrast, the deletion of both DAP10 and DAP12 
ablates control of MCMV to the level observed in NK cell–
depleted mice. Although either signaling subunit is sufficient 
for NK cell–mediated killing of m157-bearing targets, we 
find that DAP10 is necessary for optimal Ly49H-mediated 
activation of ERK1/2, NK cell proliferation, IFN- produc-
tion, and control of MCMV infection. Thus, Ly49H must 
associate with both DAP10 and DAP12 to induce optimal 
NK cell–mediated immunity to MCMV.
RESULTS
DAP12 is not required for Ly49H-dependent  
NK cell–mediated cytotoxicity and proliferation
In analyzing NK cells from DAP12-deficient mice, we found 
that Ly49H was detected on a similar frequency of NK cells in 
both WT and DAP12-deficient B6 mice, although receptor 
abundance on DAP12-deficient NK cells was 10-fold lower 
than on WT NK cells, as determined by measuring the mean 
fluorescence intensity (MFI) of Ly49H staining by flow cy-
tometry (P < 0.001; Fig. 1 A). To determine whether Ly49H 
is functional in the absence of DAP12 during MCMV infec-
tion, we assayed killing of m157-transfected Ba/F3 target cells 
ex vivo by NK cells directly isolated from MCMV-infected 
mice. As shown in Fig. 1 B, similar to WT NK cells, NK cells 
from DAP12-deficient mice preferentially killed m157-bear-
ing Ba/F3 target cells compared with the untransfected Ba/F3 
target cells. Although the absolute level of cytotoxicity medi-
ated by WT or mutant NK cells that were assayed immediately 
ex vivo from MCMV-infected mice varied somewhat between 
experiments, in all cases we observed significant killing of 
m157-bearing targets by DAP12-deficient NK cells. Lysis was 
abrogated in the presence of a blocking anti-Ly49H mAb in 
both cases, confirming that killing of Ba/F3-m157 by both WT 
and DAP12-deficient cells was mediated by Ly49H (Fig. 1 B). 
These results demonstrate that Ly49H is functional and can 
mediate cytotoxicity in the absence of DAP12. The higher 
background killing of untransfected targets by DAP12-defi-
cient NK cells has been noted previously (41). In prior studies 
using NK cells cultured for 1 wk in IL-2, we did not observe 
Ly49H-dependent cytotoxicity using NK cells from DAP12-
deficient mice (2); however, in our present studies we have 
analyzed NK cells directly ex vivo from MCMV-infected 
mice, which is more physiologically relevant.
In addition to lysis of target cells, NK cells can produce 
effector cytokines, such as IFN-, upon activating NKR 
engagement (42). Unlike WT NK cells, DAP12-deficient 
NK cells failed to produce IFN- upon antibody-mediated 
activating human KIR (1). Conversely, NKG2D is the only 
activating NKR known to associate with DAP10 and initiate 
NK cell immune responses in vivo (13). Based on the struc-
tural similarity of DAP10 and DAP12, particularly within 
their transmembrane domains, which mediate receptor–adap-
tor association, it is reasonable to expect that receptors known 
to associate with DAP12 might also complex with DAP10. 
However, the alternatively spliced isoform of NKG2D, 
which is designated NKG2D-S, expressed by activated mouse 
but not human NK cells, is the only receptor known to pair 
with both DAP10 and DAP12 in vivo (14–16). Signaling 
downstream of these adaptors differs as ITAM-containing 
adaptors recruit Syk or ZAP-70, whereas DAP10 recruits the 
p85 subunit of PI3 kinase and Grb2 (8, 17–21). NK cells ac-
tivated via ITAM-containing subunits proliferate, produce 
cytokines, and are cytotoxic, whereas cells activated through 
DAP10 are triggered to kill but do not efficiently induce the 
production of cytokines (14, 15, 19, 22, 23). Importantly, in 
human NK cells, NKG2D signaling via DAP10 augments 
IFN- and GM-CSF production induced by an activating 
DAP12-associated KIR; thus, signaling through both adap-
tors induces a more robust immune response (22).
Lack of NK cells renders both humans and mice suscepti-
ble to certain infections, particularly the herpesviruses, in-
cluding human CMVs and MCMVs (24–26). Therefore, 
experimental infection of mice with MCMV provides an in-
structive model for studying NK cell responses to viral infec-
tion. The Ly49H receptor, which is expressed on a subset of 
NK cells in C57BL/6 (B6) mice, binds to the m157 glyco-
protein encoded by MCMV and is the dominant receptor 
responsible for NK cell–mediated resistance to MCMV in B6 
mice (2, 6, 27–29). Ly49H+ NK cells control MCMV repli-
cation by both direct cytotoxic mechanisms and by secretion 
of IFN- (30, 31). Genetic ablation of Ly49H, treatment 
with Ly49H blocking antibody, or infection with a mutant 
MCMV lacking m157 (m157) renders normally resistant 
B6 mice susceptible to MCMV (32–34). Dokun et al. (35) 
have reported that early after infection with MCMV, both 
Ly49H+ and Ly49H, NK cells become activated and prolif-
erate, presumably as a result of the proinflammatory cytokine 
environment. However, by 3 d after infection Ly49H+ NK 
cells preferentially proliferate, and by 6 d the percentage of 
Ly49H+ NK cells increases from 50 to 80–90% of the total 
NK cell population (35). In B6 mice in which the ITAM of 
DAP12 had been altered to prevent association with Syk or 
ZAP-70 (designated as DAP12ki or KARAPki mice), this 
preferential expansion of Ly49H+ NK cells was lost (36, 37). 
Furthermore, these mice exhibited increased viral burden 
and histopathology (38).
Recently, Coudert et al. (39) suggested an association be-
tween Ly49H and DAP10 based on transient transfection ex-
periments and coimmunoprecipitation from IL-2–cultured 
NK cells, and prior studies have suggested an association of 
mouse SIRP-1 with DAP10 or DAP12 in a rat mast cell 
leukemia transfectant model (40). However, it remains un-
known whether Ly49H–DAP10 complexes are functionally 
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Figure 1. DAP12-independent Ly49H expression and function. (A) Peripheral blood NK cells (NK1.1+ TCR-) from uninfected B6 WT and DAP12-
deficient mice were stained for Ly49H (solid lines) or with an isotype-matched control mAb (gray fill). The bars indicate the Ly49H+ gate. The MFI ± SEM 
of Ly49H for the Ly49H+ NK cells are indicated within the graphs (n = 5 mice). Data are representative of three experiments with similar results.  
(B) Splenocytes from B6 WT or DAP12-deficient mice infected 6 d prior with MCMV-Smith were enriched for NK cells and incubated for 6 h with 51Cr-
labeled parental Ba/F3 cells (dotted lines) or Ba/F3 cells expressing MCMV m157 in the presence (dashed lines) or absence (solid lines) of Ly49H blocking 
antibody. Data are representative of four independent experiments with similar results. Error bars indicate SEM. (C and D) NK cells enriched as in B were 
incubated in the presence of brefeldin A on plates coated with anti-Ly49H, anti-NK1.1, or an isotype-matched control mAb. After 4 h, cells were stained 
for intracellular IFN- production. (C) Representative graphs are gated on NK cells (DX5+ TCR-). In the top panels, stimulation with plate-bound anti-
Ly49H prevented subsequent staining with fluorochrome-conjugated anti-Ly49H mAb. (D) Frequency of IFN- production by mAb-stimulated NK cells 
from five WT or six DAP12-deficient mice. Data are pooled from two experiments. The means of the groups are indicated by the horizontal lines. (E) B6 WT 
or DAP12-deficient splenocytes were labeled with 0.5 µM CFSE and adoptively transferred into CD45.1+CD45.2+ WT recipients. 7 d after infection with 
MCMV-Smith or -m157, mice were analyzed for CFSE dilution in donor Ly49H+ (black lines) or Ly49H (gray fill) splenic NK (NK1.1+ TCR-) cells. Data 
are representative of three experiments.
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DAP12-deficient Ly49H+ NK cells contribute  
to MCMV clearance
Brown et al. (34) have previously shown that blocking the 
Ly49H receptor abrogated NK cell control of MCMV infec-
tion, elevating viral titers to the level observed when mice had 
been depleted of NK cells. Although DAP12-deficient mice 
exhibited high MCMV titers, treatment with an anti-Ly49H 
blocking mAb significantly increased the viral titers in both the 
liver and spleen of DAP12-deficient mice compared with PBS-
treated DAP12-deficient mice (P < 0.01; Fig. 2). Thus, Ly49H+ 
NK cells exert a demonstrable level of control of MCMV infec-
tion in both organs in a DAP12-independent manner.
DAP12-independent Ly49H expression and function  
is mediated by DAP10
Recently, we have generated mice in which the genes en-
coding both DAP10 and DAP12 have been deleted (desig-
nated DAP10–DAP12-deficient) (44). NK cell numbers, 
development, and expression of inhibitory receptors in these 
cross-linking of the Ly49H receptor ex vivo (Fig. 1, C and D). 
However, DAP12-deficient NK cells are not universally im-
paired in IFN- production because cross-linking of the 
FcRI-associated receptor NK1.1 induced more IFN- 
production by DAP12-deficient NK cells than by WT NK 
cells, which is consistent with a prior study (43).
To determine whether DAP12-deficient Ly49H+ NK 
cells proliferate after MCMV infection, we labeled DAP12-
deficient or WT splenocytes with CFSE and transferred 
these cells into separate CD45-congenic recipients. 7 d after 
infection with MCMV, the transferred Ly49H+ WT NK 
cells had completely diluted their CFSE, indicating they had 
undergone at least seven rounds of division. Conversely, 
WT Ly49H NK cells retained high amounts of CFSE, in-
dicating that they had not undergone extensive proliferation 
(Fig. 1 E). Similarly, DAP12-deficient Ly49H+ NK cells di-
luted CFSE further than DAP12-deficient Ly49H NK cells 
from the same host, indicating that DAP12-deficient Ly49H+ 
NK cells had preferentially proliferated, although not to the 
same extent as WT cells. Selective proliferation by both WT 
and DAP12-deficient Ly49H+ NK cells depended on the 
presence of the cognate m157 ligand because Ly49H+ NK 
cells of either genotype failed to proliferate when recipient 
mice were infected with an MCMV virus lacking m157 
(MCMV-m157; Fig. 1 E).
To confirm that triggering Ly49H is able to drive NK cell 
proliferation during MCMV infection in a DAP12-indepen-
dent manner, we assessed BrdU incorporation by NK cells in 
WT and DAP12-deficient mice during MCMV infection. 
Similar to WT NK cells, DAP12-deficient Ly49H+ NK cells 
exhibited a strong preferential incorporation of BrdU com-
pared with Ly49H cells. This MCMV-driven proliferation 
depended on triggering Ly49H, as BrdU incorporation was 
severely reduced in both WT and DAP12-deficient mice in-
fected with MCMV-m157 (Fig. S1). These data indicate 
that cognate Ly49H–m157 interactions can drive NK cell 
proliferation in a DAP12-independent manner.
Figure 2. Ly49H-dependent but DAP12-independent control of 
MCMV. DAP12-deficient mice were treated with PBS or a nondepleting 
blocking Ly49H mAb 1 d before infection with MCMV. 3 d after infection, 
MCMV titers in the spleens (A) and liver (B) were determined by plaque 
assay. The means of the groups are indicated by the horizontal lines. Data 
are representative of two experiments with similar results.
Figure 3. Ly49H expression and function requires DAP10 or 
DAP12. (A) Peripheral blood NK cells (NK1.1+ TCR-) from uninfected 
DAP12-deficient and DAP10–DAP12-deficient mice were stained for 
Ly49H (solid lines) or with an isotype-matched control mAb (gray fill). The 
bars indicate the Ly49H+ gate. The MFI ± SEM of Ly49H for the Ly49H+ NK 
cells are indicated within the graphs (n = 5 mice). Data are representative 
of two experiments with similar results. (B) Splenocytes from DAP12-
deficient (circles) and DAP10–DAP12-deficient (squares) mice infected 6 d 
prior with MCMV-Smith were enriched for NK cells and incubated for 6 h 
with 51Cr-labeled parental Ba/F3 cells (dashed lines) or Ba/F3 cells ex-
pressing MCMV m157 (solid lines). Error bars indicate SEM. Data are rep-
resentative of two experiments with similar results.
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mice, the intensity of Ly49H staining on NK cells from 
DAP10-deficient mice was 25% lower than on NK cells 
from WT mice (P < 0.001), indicating that DAP10 enhances 
Ly49H expression in the presence of DAP12 (Fig. 5 A). As 
with DAP12-deficient NK cells, DAP10-deficient NK cells 
killed m157-bearing cells with a similar efficiency to that of 
WT NK cells (Figs. 1 B and 5 B). Lysis of m157 targets by 
both WT and DAP10-deficient cells was dependent on Ly49H 
because killing was abrogated by blocking Ly49H.
To determine whether Ly49H–DAP10 is able to enhance 
IFN- mediated by Ly49H–DAP12, we compared IFN- 
production induced by antibody-mediated cross-linking of 
Ly49H on WT and DAP10-deficient NK cells. In the ab-
sence of DAP10, cross-linking Ly49H led to diminished IFN-
 production compared with WT NK cells. Fewer cells made 
IFN-, and less cytokine was made by the IFN-+ DAP10-
deficient NK cells as indicated by the lower MFI of IFN- in 
these cells (Fig. 5 C and Fig. S3). Similar frequencies of 
DAP10-deficient and WT NK cells produced IFN- after 
stimulation via the NK1.1 receptor, and the amount of cyto-
kine produced was similar between DAP10-deficient and 
WT NK cells, indicating that the DAP10 requirement for 
IFN- production was specific for the Ly49H receptor (Fig. 5 C 
and Fig. S3 A). Thus, although Ly49H–DAP10 alone was not 
sufficient to induce IFN- production after receptor cross-
linking (Fig. 1 D), the Ly49H–DAP10 receptor complexes 
synergize with Ly49H–DAP12 receptor complexes to pro-
duce optimal IFN- in Ly49H-stimulated WT NK cells.
To determine whether DAP10 is required for Ly49H-
dependent NK cell proliferation during MCMV infection, 
we transferred a 1:1 mixture of congenically marked WT and 
DAP10-deficient splenocytes into naive recipients and then 
infected with MCMV. 6 d after infection, the WT donor 
NK cells expanded more than the donor DAP10-deficient 
NK cells, as indicated by the increased frequency of WT cells 
compared with DAP10-deficient cells among the donor cell 
population. This was confirmed by examining CFSE dilution 
in WT and DAP10-deficient NK cells after MCMV infec-
tion. Although both populations exhibited considerable 
CFSE dilution, the WT NK cells underwent more rounds of 
division than the DAP10-deficient NK cells, confirming that 
DAP10 is required for optimal NK cell proliferation during 
MCMV infection (Fig. S3).
To determine how DAP10 augments DAP12 signaling 
downstream of Ly49H, we compared signaling events in primary 
NK cells from MCMV-infected WT and DAP10-deficient mice 
upon restimulation with an anti-Ly49H mAb. Prior studies have 
established that ERK1/2 is phosphorylated after stimulation via 
DAP10 and DAP12 and is critical to ITAM-induced NK cell ef-
fector functions (21, 47). Therefore, we analyzed the activation 
of ERK1/2 in response to Ly49H cross-linking in primary NK 
cells isolated directly ex vivo from MCMV-infected mice. Com-
pared with WT NK cells, DAP10-deficient NK cells demon-
strated reduced phosphorylation of the ERK1/2 kinases early 
after Ly49H triggering (Fig. 6, A and B). Thus, DAP10 is re-
quired for optimal signaling downstream of Ly49H.
mice were similar to that in NK cells from WT mice, al-
though minor alterations in expression of certain inhibitory 
Ly49 receptors were observed (Fig. S2). In contrast to the 
DAP12-deficient mice, surface expression of Ly49H was totally 
ablated in mice lacking both DAP10 and DAP12 (Fig. 3 A), 
indicating that in the absence of DAP12, DAP10 allows for 
the expression of Ly49H. Unlike DAP12-deficient NK cells, 
NK cells from DAP10–DAP12-deficient mice failed to kill 
m157-expressing target cells, confirming that in the absence 
of DAP12, DAP10 mediates the Ly49H-dependent functions 
(Fig. 3 B). 4 d after infection, MCMV titers in the spleens 
and livers of DAP10–DAP12-deficient mice were signifi-
cantly higher than in DAP12 singly deficient mice (P < 
0.0001 and P < 0.05, respectively) and similar to those found 
in DAP12-deficient mice depleted of NK cells (Fig. 4), con-
firming that the DAP12-independent protection mediated 
by Ly49H is DAP10 dependent and that all DAP12-inde-
pendent NK cell–dependent control requires DAP10. This 
DAP10 dependency is not caused by NKG2D because all 
animals were treated with saturating amounts of anti-NKG2D 
blocking mAb and prior studies have established that NKG2D 
does not contribute to the control of infection with WT 
MCMV because the virus ablates expression of NKG2D li-
gands on MCMV-infected cells (45, 46).
DAP10 is required for optimal Ly49H expression  
and function
To determine whether DAP10 is involved in Ly49H expres-
sion and functions when DAP12 is present, we compared 
Ly49H expression and functions in WT and DAP10-deficient 
mice, both of which express DAP12. Although the frequency 
of Ly49H+ NK cells was similar in WT and DAP10-deficient 
Figure 4. DAP10 contributes to DAP12-independent control of 
MCMV. DAP12-deficient mice treated with anti-NKG2D mAb and either 
undepleted or depleted of NK cells and DAP10–DAP12-deficient mice 
treated with anti-NKG2D mAb were infected with MCMV. Viral titers in 
the spleens (A) and livers (B) at 4 d after infection were determined by 
plaque assay. The means of the groups are indicated by the horizontal 
lines. Data are representative of two experiments with similar results.
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Figure 5. DAP10-dependent functions of Ly49H. (A) Peripheral blood NK cells (NK1.1+ TCR-) from uninfected B6 WT and DAP10-deficient mice 
were stained for Ly49H (solid lines) or with an isotype-matched control mAb (gray fill). The bars indicate the Ly49H+ gate. The mean MFI ± SEM of Ly49H 
for the Ly49H+ NK cells are indicated within the graphs (n = 5 mice). Data are representative of three experiments with similar results. (B) Splenocytes 
from B6 WT or DAP10-deficient mice infected 6 d prior with MCMV-Smith were enriched for NK cells and incubated for 6 h with 51Cr-labeled parental  
Ba/F3 cells (dotted lines) or Ba/F3 cells expressing MCMV m157 in the presence (dashed lines) or absence (solid lines) of Ly49H blocking antibody. Data are 
representative of three independent experiments with similar results. Error bars indicate SEM. (C) Enriched NK cells from MCMV-infected WT and DAP10-
deficient mice were stained for IFN- production after incubation for 4 h in the presence of brefeldin A on plates coated with anti-Ly49H, anti-NK1.1, or 
an isotype-matched control mAb. The means of the groups are indicated by the horizontal lines. Data are pooled from two experiments. (D) WT and 
DAP10-deficient splenocytes were mixed 1:1 and adoptively transferred into naive hosts. Before infection and 6 d after infection with MCMV-Smith or 
-m157, recipient mice were bled and analyzed for the frequency of WT (CD45.1) and DAP10-deficient (CD45.2) donor NK (NK1.1+ TCR-) cells. The plot 
indicates the ratio of WT to DAP10-deficient donor NK cells in four animals before infection (day 0) and 6 d after infection. Data are representative of five 
independent experiments with similar results.
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DAP10 is required for late control of MCMV infection
To determine whether DAP10-augmented Ly49H functions 
contribute to control of MCMV infection, we compared vi-
ral titers in the spleens and livers of WT and DAP10-defi-
cient mice 4 d after MCMV infection. Although DAP10- 
deficient mice demonstrated elevated viral titers in both 
organs compared with viral titers in WT mice, the differences 
did not reach the level of statistical significance (Fig. 7, A and B). 
This is likely a result of the ability of DAP10-deficient NK 
cells expressing Ly49H–DAP12 complexes to efficiently lyse 
m157-bearing targets and to produce intermediate amounts 
of IFN- (Fig. 5, B and C).
To determine whether DAP10-enhanced proliferation of 
Ly49H+ NK cells contributed to control of MCMV at later 
time points, we assessed viral titers 1 wk after infection in 
WT and DAP10-deficient mice. Although both WT and 
DAP10-deficient mice cleared MCMV from the spleen and 
liver at this time point, the DAP10-deficient mice had 20× 
higher viral titers in the salivary glands (P < 0.001; Fig. 7 C), 
which is the site where MCMV persists in the chronically in-
fected host. Thus, DAP10 is required for optimal control of 
MCMV at later time points in the salivary glands, possibly 
because of DAP10-dependent enhanced NK cell prolifera-
tion and/or IFN- production.
DISCUSSION
Recent biochemical studies have suggested that DAP10 may 
associate with NKRs other than NKG2D, including Ly49D 
and Ly49H (39). We now demonstrate that not only do 
these Ly49H–DAP10 complexes form but that they are able 
to induce NK cell functions, including proliferation, cyto-
toxicity, and cytokine production, and, most importantly, 
that Ly49H–DAP10 complexes are required for optimal 
control of MCMV infection. By comparing WT, DAP10-
deficient, DAP12-deficient, and DAP10–DAP12-deficient 
mice, we found that DAP10 alone is sufficient to mediate 
some Ly49H-dependent NK cell functions and that DAP10 
and DAP12 together are necessary for optimal Ly49H-medi-
ated NK activity and control of MCMV infection. In the 
absence of DAP12, DAP10 was sufficient to support the sur-
face expression of Ly49H, Ly49H-dependent NK cell–me-
diated cytotoxicity, NK cell proliferation, and control of 
MCMV. However, DAP10 alone was not sufficient for 
Ly49H-induced IFN- production. Even in the presence of 
DAP12, DAP10 was required for optimal Ly49H expression, 
IFN- production, proliferation, and control of MCMV 
infection. Thus, we hypothesize that Ly49H signaling via 
DAP10 augments the DAP12-mediated proliferation and 
cytokine production of Ly49H+ NK cells, resulting in optimal 
NK cell control of MCMV infection.
Figure 6. Ly49H signaling is impaired in the absence of DAP10.  
(A) Splenic NK cells (DX5+ TCR-) from B6 WT and DAP10-deficient mice 
infected 6 d prior with MCMV-Smith were sorted to >93% purity and 
incubated on Ly49H mAb-coated plates for 0–20 min. Cells were lysed, 
run on a 10% SDS-PAGE gel, and blotted for total and phosphorylated 
ERK1/2. ‘, min. (B) Integrated band densities were calculated using ImageJ 
software and plotted as a ratio of phosphorylated ERK1/2 to total ERK1/2. 
Data are representative of three experiments with similar results.
Figure 7. DAP10 is required for optimal control of late MCMV 
infection. B6 WT and DAP10-deficient mice were treated with blocking 
anti-NKG2D mAb and, 1 d later, infected with MCMV. Viral titers in the 
spleens (A) and liver (B) at 4 d after infection and in the salivary glands 
(C) at 7 d after infection were determined by plaque assay. No virus was 
recovered from the spleens or livers at day 7. The means of the groups are 
indicated by the horizontal lines. Data are pooled from two experiments 
with similar results.
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suggesting that the DAP10 and DAP12 signaling cascades in-
tersect at this molecule in an additive or synergistic manner. 
ERK1/2 activation is known to be upstream of IFN- transcrip-
tion; thus, the partial defect in IFN- production by DAP10-
deficient NK cells downstream of Ly49H might be caused by 
inefficient activation of ERK1/2 (48, 49). Similarly, CD45-de-
ficient NK cells exhibit minimal phosphorylation of ERK1/2 
and IFN- production upon triggering of multiple ITAM-asso-
ciated receptors; however, cytolytic activity induced by these 
same receptors was maintained in the Cd45/ NK cells, sug-
gesting that weak activation of ERK1/2 may be sufficient for 
NK cell–mediated killing but not IFN- production (50).
Ly49H is the dominant receptor in NK cell–mediated 
control of MCMV in B6 mice (34). In addition to the previ-
ously reported DAP12-dependent mechanism of MCMV 
control (38), we find a DAP12-independent mechanism of 
control of MCMV that is dependent on both Ly49H and 
DAP10. Compared with DAP12-deficient mice, mice lack-
ing both DAP10 and DAP12 demonstrated elevated MCMV 
titers in both the spleen and the liver similar to that seen in 
DAP12-deficient mice treated with blocking Ly49H anti-
body or depleted of NK cells. The most striking defect in 
MCMV control in DAP10-deficient mice is evident in the 
salivary glands 1 wk after infection. As Ly49H+ NK cells in 
DAP10-deficient mice are partially impaired in their prolif-
erative response to MCMV, it is possible that efficient control 
of MCMV in the salivary glands is dependent on expansion 
of Ly49H+ NK cells. Furthermore, a DAP10-dependent 
contribution to IFN- production might also be involved in 
control of viral replication in the salivary gland. The DAP10-
dependent control of MCMV in the absence of DAP12 is 
unlikely to be caused by NKG2D because MCMV encodes 
at least four proteins that prevent expression of NKG2D 
ligands on the surface of infected cells (45, 46, 51–53), and 
NKG2D-deficient mice control MCMV infection as efficiently 
as WT mice (Dan Serna and David Raulet, personal com-
munication). Thus, although DAP12-deficient mice are im-
paired in their Ly49H-dependent response against MCMV 
infection (54), we now show that DAP10 enables some Ly49H 
function in the absence of DAP12 and is necessary for optimal 
activity in the presence of DAP12.
Although DAP10 and DAP12 make unequal contribu-
tions to Ly49H-mediated function, it is clear that both are 
required for optimal NK cell responses to MCMV. The sig-
naling events known to be induced by DAP10 receptor trig-
gering are also induced by DAP12 (48). Thus, DAP12 
activation could theoretically supersede DAP10 activation. 
However, it is possible that engaging both pathways induces 
a quantitatively more robust signal, as demonstrated by the 
stronger ERK1/2 activation seen in WT NK cells compared 
with DAP10-deficient NK cells triggered via Ly49H. Alter-
natively, DAP10 triggering might engage an unknown sig-
naling pathway that is not shared with DAP12. Regardless, 
we demonstrate that DAP12-induced DAP10-augmented 
NK cell responses initiated by Ly49H-mediated recognition 
of m157 provide for the optimal NK cell response during 
Surface expression of Ly49H on NK cells requires either 
DAP10 or DAP12, as demonstrated by the total absence of 
Ly49H on NK cells in DAP10–DAP12 doubly deficient 
mice. In singly deficient NK cells, the reduction in Ly49H 
surface level is more pronounced in DAP12-deficient cells 
than in DAP10-deficient cells. At least two possibilities might 
explain this difference. First, Ly49H–DAP10 receptor com-
plexes might be less stable than Ly49H–DAP12 receptor 
complexes. Second, the amount of DAP10 protein in NK 
cells might be limiting or being preferentially used by other 
receptors, such as NKG2D. Given the sequence similarity of 
the transmembrane domains of DAP10 and DAP12, which 
determine receptor–adaptor pairing, it is anticipated that 
other DAP12-associated receptors will be found to associate 
with DAP10. Indeed, we have also observed an association of 
Ly49D and mouse CD94/NKG2C with DAP10 (unpub-
lished data), which is in agreement with recent findings (39). 
It is important to note that our results indicate that DAP10 
deficiency not only abrogates the functions of the NKG2D-L 
receptor but also affects the functions of other activating 
NKRs that were previously only known to associate with 
DAP12 in vivo.
During MCMV infection, the Ly49H+ subset of NK cells 
proliferates extensively. Using DAP12ki mice in which the 
ITAM of DAP12 was mutated to be nonfunctional, French 
et al. (36) showed that the selective BrdU incorporation by 
Ly49H+ NK cells during MCMV infection required DAP12 
signaling. Conversely, we found that DAP12-deficient Ly49H+ 
NK cells preferentially incorporated BrdU during MCMV in-
fection. It is possible that the DAP12ki homodimer might be 
acting as a dominant negative, preventing DAP10 from associ-
ating with Ly49H and thus accounting for the differences be-
tween the DAP12ki and the DAP12-deficient NK cells. By 
adoptively transferring CFSE-labeled cells, we found that 
either DAP10 or DAP12 was sufficient to mediate proliferation 
of Ly49H+ NK cells during MCMV infection. However, 
maximal proliferation required both signaling subunits because 
WT NK cells outcompeted DAP10-deficient NK cells when 
cells of both genotypes were transferred into the same host.
Engaging receptors associated with ITAM adaptors (DAP12, 
CD3-, or FcRI), such as the KIR2DS1–DAP12 receptor 
complex, results in both cytotoxicity and cytokine secretion. In 
contrast, triggering the DAP10-associated NKG2D receptor 
leads to cytotoxicity but not efficient cytokine secretion (19, 
23). We previously reported that when we simultaneously 
cross-linked both KIR2DS2–DAP12 and NKG2D–DAP10 
on human NK cells, DAP10 activation augmented DAP12-in-
duced IFN- production (22). We now show that by trigger-
ing a single receptor, i.e., Ly49H, both the DAP10 and DAP12 
signaling pathways are engaged and lead to optimal IFN- pro-
duction in WT NK cells, whereas either signaling subunit is 
sufficient to trigger NK cell–mediated cytotoxicity. Signaling 
downstream of DAP10 and DAP12 engages some of the same 
pathways, including the ERK1/2 pathway (21, 47, 48). Com-
pared with WT NK cells, cross-linking Ly49H on DAP10-defi-
cient NK cells lead to only a modest induction of ERK1/2, 
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crystal violet dye. Splenic and salivary gland titers were calculated for the 
whole organ and liver titers were adjusted for weight of the tissue.
Western blot analysis. Splenic NK cells from WT and DAP10-deficient 
mice infected with MCMV 6 d prior were sorted as DX5+ TCR- to 
>93% purity based on NK1.1 expression. Sorted cells were incubated 
with 10 µg/ml of purified anti-CD16+CD32 mAb 2.4G2 to block Fc re-
ceptors and then rested for 1 h without serum at 37°C. Cells were added 
to plates coated with Ly49H mAb, incubated at 37°C, and lysed with 
Laemmli Sample buffer (Bio-Rad Laboratories). Lysates were boiled, sep-
arated on a 10% SDS-PAGE gel, and transferred to an Immobilon P mem-
brane. Blots were blocked with 5% BSA in TBS-Tween and then probed 
with anti–phospho-ERK1/2 or anti–total ERK1/2 (Cell Signaling Tech-
nology). Primary antibodies were detected with HRP-conjugated anti–
rabbit IgG antibody (Cell Signaling Technology) and visualized with ECL 
Plus (GE Healthcare). Quantitation of the integrated density of bands mi-
nus background was performed using ImageJ software (National Institutes 
of Health).
Statistical analysis. Statistical differences in MFIs and percentages of IFN-+ 
NK cells were determined by the unpaired two-tailed Student’s t test. Statis-
tical differences in viral titers were determined by the unpaired two-tailed 
Mann-Whitney U test. Statistical differences in the ratio of WT and DAP10-
deficient NK cells before and after infection were determined by the paired 
two-tailed Student’s t test. Statistics were determined with Prism software 
(GraphPad Software, Inc.).
Online supplemental material. Fig. S1 shows in vivo BrdU incorpora-
tion by WT and DAP12-deficient Ly49H+ NK cells during MCMV infec-
tion. Fig. S2 shows expression of NKRs, maturation, and activation status of 
NK cells from naive DAP10–DAP12-deficient mice. Fig. S3 shows IFN- 
production and CFSE dilution by WT and DAP10-deficient Ly49H+ NK 
cells during MCMV infection. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20090168/DC1.
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